Subverted macrophages in the triple-negative breast cancer ecosystem

Changgang Sun(Weifang Chinese Medicine Hospital), Xue Wang(Northwestern Polytechnical University), Wen‐Feng Zhang(Shandong University of Traditional Chinese Medicine), Yan Yao(Shandong University of Traditional Chinese Medicine), Yuting Zhong(Chengdu Medical College), Jingyang Liu(Shandong University of Traditional Chinese Medicine), Cun Liu(Weifang Medical University), Lu Wang(People's Hospital of Xinjiang Uygur Autonomous Region)
Biomedicine & Pharmacotherapy
September 4, 2023
10.1016/j.biopha.2023.115414
Cited by 18

Related Papers

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
|The Lancet|2023|514
CA-TIMS zircon U–Pb dating of felsic ignimbrite from the Binchuan section: Implications for the termination age of Emeishan large igneous province
|Lithos|2014|258
Erythrocyte Membrane-Coated Upconversion Nanoparticles with Minimal Protein Adsorption for Enhanced Tumor Imaging
|ACS Applied Materials & Interfaces|2017|246
Antitumor Platelet‐Mimicking Magnetic Nanoparticles
|Advanced Functional Materials|2017|217
Cancer Stem Cell‐Platelet Hybrid Membrane‐Coated Magnetic Nanoparticles for Enhanced Photothermal Therapy of Head and Neck Squamous Cell Carcinoma
|Advanced Functional Materials|2019|208